EE9900039A - Paratüreoidhormooni analoogid osteoporoosi raviks - Google Patents

Paratüreoidhormooni analoogid osteoporoosi raviks

Info

Publication number
EE9900039A
EE9900039A EEP199900039A EE9900039A EE9900039A EE 9900039 A EE9900039 A EE 9900039A EE P199900039 A EEP199900039 A EE P199900039A EE 9900039 A EE9900039 A EE 9900039A EE 9900039 A EE9900039 A EE 9900039A
Authority
EE
Estonia
Prior art keywords
analogues
lys
activities
parathyroid hormone
rat
Prior art date
Application number
EEP199900039A
Other languages
English (en)
Estonian (et)
Inventor
Barbier Jean-Ren�
Morley Paul
Neugebauer Witold
Ross Virginia
Whitfield James
E. Willick Gordon
Original Assignee
National Research Council Of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,647 external-priority patent/US5955425A/en
Application filed by National Research Council Of Canada filed Critical National Research Council Of Canada
Publication of EE9900039A publication Critical patent/EE9900039A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Radiation (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
EEP199900039A 1996-08-02 1997-08-01 Paratüreoidhormooni analoogid osteoporoosi raviks EE9900039A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/691,647 US5955425A (en) 1996-08-02 1996-08-02 Parathyroid hormone analogues for the treatment of osteoporosis
US4056097P 1997-03-14 1997-03-14
PCT/CA1997/000547 WO1998005683A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
EE9900039A true EE9900039A (et) 1999-08-16

Family

ID=26717175

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900039A EE9900039A (et) 1996-08-02 1997-08-01 Paratüreoidhormooni analoogid osteoporoosi raviks

Country Status (24)

Country Link
EP (1) EP0915911B1 (is)
JP (3) JP4122061B2 (is)
KR (1) KR100500859B1 (is)
CN (1) CN1176947C (is)
AT (1) ATE253078T1 (is)
AU (1) AU723728B2 (is)
BG (1) BG103128A (is)
BR (1) BR9711002B1 (is)
CA (1) CA2261564C (is)
CZ (1) CZ34799A3 (is)
DE (1) DE69725850T2 (is)
DK (1) DK0915911T3 (is)
EE (1) EE9900039A (is)
ES (1) ES2207740T3 (is)
FI (1) FI990126A7 (is)
GE (1) GEP20033095B (is)
IS (1) IS4962A (is)
LV (1) LV12293B (is)
NZ (1) NZ333809A (is)
PT (1) PT915911E (is)
RU (1) RU2203286C2 (is)
SI (1) SI9720057A (is)
SK (1) SK287397B6 (is)
WO (1) WO1998005683A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK151599A3 (en) * 1997-05-14 2000-09-12 Rhone Poulenc Rorer Pharma Peptide parathyroid hormone analogs
AU1447600A (en) 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
DE69942035D1 (de) 1998-11-25 2010-04-01 Gen Hospital Corp Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
EP1141237B1 (en) 1998-12-31 2005-11-02 The General Hospital Corporation Pth receptor and screening assay utilizing the same
AU777634B2 (en) * 1999-07-28 2004-10-28 Kazuhiro Aoki Methods of inhibiting osteoclastogenesis
US6316410B1 (en) * 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
CA2454275C (en) 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
EP1420827B8 (en) * 2001-08-17 2009-12-23 Novartis AG 5-cnac as oral delivery agent for parathyroid hormone fragments
AU2003207512B2 (en) 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
EP1567178A4 (en) * 2002-11-01 2009-07-15 Amgen Inc MODULATORS OF RECEPTORS FOR NEUTRAL THERAPY HORMONE AND SIDE-HORSE HORMONE-RELATED PROTEINS
CN100508957C (zh) * 2003-01-21 2009-07-08 尤尼金实验室股份有限公司 肽经口输递的改进
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2007130113A2 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
JP2010501476A (ja) * 2006-07-31 2010-01-21 ゼロス セラピューティクス， インコーポレイテッド 副甲状腺ホルモン類似体およびその使用方法
AU2007313001B2 (en) 2006-10-13 2012-03-22 Eli Lilly And Company Pegylated PTH as PTH receptor modulators and uses thereof
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
WO2011143406A2 (en) * 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
EP3655104A4 (en) 2017-07-15 2021-03-17 The Regents of the University of California CATHEPSIN K OSTEOADSORBANT FLUOROGENIC SUBSTRATE FOR IMAGING OF OSTEOCLAST ACTIVITY AND MIGRATION
CN119931216A (zh) 2018-09-26 2025-05-06 博里利斯股份公司 具有优异的光学和机械性能的丙烯共聚物组合物
CN113549144A (zh) * 2021-06-30 2021-10-26 华南理工大学 一种特立帕肽hPTH(1-34)的生产和纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis

Also Published As

Publication number Publication date
IS4962A (is) 1999-01-29
JP4122061B2 (ja) 2008-07-23
AU3690597A (en) 1998-02-25
AU723728B2 (en) 2000-09-07
JP2007254480A (ja) 2007-10-04
JP4224111B2 (ja) 2009-02-12
CN1176947C (zh) 2004-11-24
GEP20033095B (en) 2003-10-27
PT915911E (pt) 2004-03-31
SI9720057A (sl) 1999-12-31
JP2001500845A (ja) 2001-01-23
LV12293B (en) 2000-11-20
FI990126L (fi) 1999-03-31
EP0915911A1 (en) 1999-05-19
DE69725850D1 (de) 2003-12-04
CA2261564C (en) 2007-10-30
ES2207740T3 (es) 2004-06-01
CN1231676A (zh) 1999-10-13
NZ333809A (en) 2000-07-28
CA2261564A1 (en) 1998-02-12
BR9711002A (pt) 2002-01-15
BG103128A (bg) 2000-05-31
BR9711002B1 (pt) 2011-09-06
FI990126A0 (fi) 1999-01-22
SK13299A3 (en) 1999-10-08
KR100500859B1 (ko) 2005-07-14
DK0915911T3 (da) 2004-03-08
KR20000029783A (ko) 2000-05-25
RU2203286C2 (ru) 2003-04-27
FI990126A7 (fi) 1999-03-31
SK287397B6 (sk) 2010-08-09
DE69725850T2 (de) 2004-08-19
WO1998005683A1 (en) 1998-02-12
LV12293A (lv) 1999-06-20
ATE253078T1 (de) 2003-11-15
CZ34799A3 (cs) 1999-07-14
JP2009057386A (ja) 2009-03-19
EP0915911B1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
EE9900039A (et) Paratüreoidhormooni analoogid osteoporoosi raviks
WO2001021643A3 (en) Parathyroid hormone analogues for the treatment of osteoporosis
Chartrel et al. Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y.
NZ502872A (en) Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases
NO992557D0 (no) Bruk av GLP-1-analoger og derivater administrert perifert i regulering av fedme
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
AU5567790A (en) Device for reinforcing and sustaining the cap of the rotators of a human shoulder joint
TR200003048T2 (tr) İnsülinin peptit analoglarının diyabet tedavisi için kullanımı.
DK413986D0 (da) Syntetisk peptid og farmaceutisk middel indeholdende peptidet
BR9610725A (pt) Análogos peptídeos cilclicos de somatostanina
EP0352014A3 (en) Cyclic grf analogs
RU99104132A (ru) Аналоги паратиреоидного гормона для лечения остеопороза
ATE377026T1 (de) Behandlung von fettleibigkeit
ATE279440T1 (de) Wachstumshormonsekretionsförderer rezeptorfamilie
EP0182627A3 (en) Basic v1-vasopressin antagonists
ITMI912582A1 (it) Mutanti dell'ormone della crescita umano e loro impiego
EP0182626A3 (en) V1-vasopressin antagonists
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
ATE178073T1 (de) Superaktive analoga des wachstumshormon- releasingfaktors
ATE412669T1 (de) Calicitonin-analoga mit stark erhöhter hypocalcämischer wirkung in vivo
FI20055480A7 (fi) BMP-4-, BMP-12-, BMP-13-ja MP-52-polypeptidien käyttö valmistettaessa sidekudoskiinnityksen regenerointiin tarkoitettuja farmaseuttisia koostumuksia
DK119391A (da) Humaninsulinanaloger